Marvell’s AI Play Triggers Aggressive Forecasts Amid Valuation Debate

Marvell Technology (NASDAQ:MRVL) has become a focal point for investors seeking exposure to AI infrastructure, after the chipmaker announced earnings that surpassed expectations and a guidance package that projects fiscal‑2028 earnings per share near $10. The revised outlook pushed analysts at multiple firms to double or even triple their price targets, reflecting confidence in Marvell’s expanding role in data‑center interconnects and custom silicon.

Cantor Fitzgerald was among the first to adjust its model, moving the target from $190 to $220 while keeping a neutral stance. The firm highlighted Marvell’s growing presence in AI‑related hardware but warned that the stock already trades at multiples comparable to peers such as NVIDIA and Broadcom. In Cantor’s view, the valuation incorporates much of the optimism, limiting upside unless the company can deliver earnings growth beyond current projections.

Deutsche Bank took a more bullish approach, lifting its target from $120 to $240 and reaffirming a buy recommendation. The German bank cited accelerating demand for data‑center components, higher revenue forecasts for fiscal years 2027 and 2028, expanding margins, and disciplined capital allocation as key drivers. Deutsche also upgraded its fiscal‑2029 earnings estimate by roughly 20%, underscoring the belief that Marvell’s AI‑centric portfolio will continue to capture market share.

Barclays and Benchmark both pushed their targets into the $270 range, with Barclays analyst Tom O’Malley noting that hyperscalers are expected to increase spending on AI infrastructure, a trend that should lift interconnect and custom silicon sales. The analysts emphasized management’s guidance indicating revenue acceleration throughout the current fiscal year, suggesting that Marvell could benefit from a multi‑year tailwind rather than a one‑off boost.

The consensus among the surveyed houses is bullish: average price forecasts sit around $225, with most firms maintaining buy or overweight ratings. However, the market pricing tells a different story. At roughly $205 in pre‑market trade, Marvell trades at about 70 times forward earnings, a premium that reflects investor appetite for AI exposure but also raises questions about risk versus reward. Compared with sector averages, the multiple is substantially higher, meaning any shortfall in guidance could trigger a sharp correction.

From a technical perspective, Marvell remains in an uptrend. The stock sits above its 20‑day and 200‑day moving averages, preserving the bullish “golden cross” pattern formed last October. Momentum indicators such as MACD are positive, supporting the view that recent pullbacks may be temporary. Nonetheless, key resistance lies near the recent high of $218.26; a break above could unlock further upside, while a fall below the 20‑day average around $178 would test the next support level.

Investors should keep an eye on the upcoming earnings release slated for August 27. Consensus estimates call for EPS of $0.86 and revenue of $2.6 billion—both sizable increases year over year. The outcome will likely determine whether the lofty valuation is justified or if a correction is warranted. For now, Marvell offers a high‑conviction play on AI infrastructure, but its elevated price tag demands careful assessment of execution risk.